Qiagen (QGEN) Stock Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

QGEN Analyst Ratings

Moderate Buy

6 Buy

6 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Qiagen

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

QGEN Stock 12 Month Forecast

Average Price Target

CHF41.54

▼(-17.51% Downside)

Based on 12 Wall Street analysts offering 12 month price targets for Qiagen in the last 3 months. The average price target is CHF41.54 with a high forecast of CHF48.29 and a low forecast of CHF36.07. The average price target represents a -17.51% change from the last price of CHF50.36.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"35":"CHF35","39":"CHF39","43":"CHF43","47":"CHF47","51":"CHF51"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":48.2924982,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF48.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":41.5395972017,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF41.54</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.07356169555983,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF36.07</span>\n  </div></div>","useHTML":true}}],"tickPositions":[35,39,43,47,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,50.36,50.2009614,50.0419228,49.8828842,49.7238456,49.564807,49.4057684,49.2467298,49.087691199999995,48.9286526,48.769614,48.610575399999995,48.4515368,{"y":48.2924982,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,50.36,49.68150747705385,49.00301495410769,48.32452243116154,47.64602990821538,46.96753738526923,46.289044862323074,45.61055233937692,44.932059816430765,44.253567293484615,43.57507477053846,42.896582247592306,42.21808972464615,{"y":41.5395972017,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,50.36,49.26104320735075,48.16208641470151,47.063129622052266,45.964172829403026,44.86521603675378,43.76625924410454,42.66730245145529,41.56834565880605,40.469388866156805,39.370432073507565,38.27147528085832,37.17251848820908,{"y":36.07356169555983,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":50.36,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.36,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF48.29

Average Price TargetCHF41.54

Lowest Price TargetCHF36.07

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Cira Diagnissa

TR | OpenAI - 4o

CHF41.36→CHF40.56

Buy

-19.46%

Downside

Reiterated

10/31/25

AI Generated ArticleAI Generated Article

Daniel Brennan

TD Cowen

CHF41.36

Hold

-17.88%

Downside

Reiterated

10/13/25

Qiagen (QGEN) Gets a Hold from TD Cowen

Luke Sergott

Barclays

CHF43.74→CHF42.15

Buy

-16.30%

Downside

Reiterated

10/02/25

Qiagen price target lowered to $53 from $55 at BarclaysQiagen price target lowered to $53 from $55 at Barclays

Michael Ryskin

Bank of America Securities

―

Buy

―

Reiterated

09/26/25

Bank of America Securities Keeps Their Buy Rating on Qiagen (QGEN)

Harry Gillis

Berenberg Bank

CHF46.28

Buy

-8.10%

Downside

Reiterated

09/23/25

Berenberg Bank Remains a Buy on Qiagen (QGEN)

Maja Pataki

Kepler Capital

CHF36.1

Hold

-28.32%

Downside

Reiterated

09/10/25

Qiagen (QGEN) Gets a Hold from Kepler Capital

Tycho Peterson

Jefferies

―

Buy

―

Reiterated

09/05/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Qiagen (NYSE: QGEN)

Jan Koch

Deutsche Bank

―

Buy

―

Reiterated

08/20/25

Qiagen (QGEN) Gets a Buy from Deutsche Bank

Daniel Arias

Stifel Nicolaus

CHF35.79

Hold

-28.94%

Downside

Reiterated

08/08/25

Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)

Dan Leonard

UBS

CHF38.17→CHF39.76

Hold

-21.04%

Downside

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Amgen (NASDAQ: AMGN) and Qiagen (NYSE: QGEN)

Andrew Brackmann

William Blair

―

Hold

―

Assigned

08/07/25

Hold Rating on Qiagen Amidst Strong Performance and Market Uncertainties

Catherine Ramsey Schulte

Robert W. Baird

CHF35.79→CHF38.97

Hold

-22.62%

Downside

Reiterated

08/07/25

Robert W. Baird Reaffirms Their Hold Rating on Qiagen (QGEN)

Casey Woodring

J.P. Morgan

CHF47.72

Buy

-5.25%

Downside

Reiterated

08/06/25

J.P. Morgan Remains a Buy on Qiagen (QGEN)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

07/28/25

DZ BANK AG Sticks to Its Buy Rating for Qiagen (QGEN)

Aisyah Noor

Morgan Stanley

CHF39.8

Hold

-20.96%

Downside

Reiterated

07/25/25

Hold Rating for Qiagen Amid Horizon Europe Funding Prospects

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Cira Diagnissa

TR | OpenAI - 4o

CHF41.36→CHF40.56

Buy

-19.46%

Downside

Reiterated

10/31/25

AI Generated ArticleAI Generated Article

Daniel Brennan

TD Cowen

CHF41.36

Hold

-17.88%

Downside

Reiterated

10/13/25

Qiagen (QGEN) Gets a Hold from TD Cowen

Luke Sergott

Barclays

CHF43.74→CHF42.15

Buy

-16.30%

Downside

Reiterated

10/02/25

Qiagen price target lowered to $53 from $55 at BarclaysQiagen price target lowered to $53 from $55 at Barclays

Michael Ryskin

Bank of America Securities

―

Buy

―

Reiterated

09/26/25

Bank of America Securities Keeps Their Buy Rating on Qiagen (QGEN)

Harry Gillis

Berenberg Bank

CHF46.28

Buy

-8.10%

Downside

Reiterated

09/23/25

Berenberg Bank Remains a Buy on Qiagen (QGEN)

Maja Pataki

Kepler Capital

CHF36.1

Hold

-28.32%

Downside

Reiterated

09/10/25

Qiagen (QGEN) Gets a Hold from Kepler Capital

Tycho Peterson

Jefferies

―

Buy

―

Reiterated

09/05/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Qiagen (NYSE: QGEN)

Jan Koch

Deutsche Bank

―

Buy

―

Reiterated

08/20/25

Qiagen (QGEN) Gets a Buy from Deutsche Bank

Daniel Arias

Stifel Nicolaus

CHF35.79

Hold

-28.94%

Downside

Reiterated

08/08/25

Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)

Dan Leonard

UBS

CHF38.17→CHF39.76

Hold

-21.04%

Downside

Reiterated

08/07/25

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Amgen (NASDAQ: AMGN) and Qiagen (NYSE: QGEN)

Andrew Brackmann

William Blair

―

Hold

―

Assigned

08/07/25

Hold Rating on Qiagen Amidst Strong Performance and Market Uncertainties

Catherine Ramsey Schulte

Robert W. Baird

CHF35.79→CHF38.97

Hold

-22.62%

Downside

Reiterated

08/07/25

Robert W. Baird Reaffirms Their Hold Rating on Qiagen (QGEN)

Casey Woodring

J.P. Morgan

CHF47.72

Buy

-5.25%

Downside

Reiterated

08/06/25

J.P. Morgan Remains a Buy on Qiagen (QGEN)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

―

Buy

―

Reiterated

07/28/25

DZ BANK AG Sticks to Its Buy Rating for Qiagen (QGEN)

Aisyah Noor

Morgan Stanley

CHF39.8

Hold

-20.96%

Downside

Reiterated

07/25/25

Hold Rating for Qiagen Amid Horizon Europe Funding Prospects

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Qiagen

1 Month

xxx

Success Rate

7/12 ratings generated profit

Average Return

+1.86%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 58.33% of your transactions generating a profit, with an average return of +1.86% per trade.

3 Months

xxx

Success Rate

11/17 ratings generated profit

Average Return

+2.94%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +2.94% per trade.

1 Year

Michael RyskinBank of America Securities

Success Rate

9/12 ratings generated profit

Average Return

+3.51%

reiterated a buy rating last month

Copying Michael Ryskin's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +3.51% per trade.

2 Years

xxx

Success Rate

11/12 ratings generated profit

Average Return

+9.42%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +9.42% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QGEN Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, QGEN has received 18 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. QGEN average Analyst price target in the past 3 months is 41.54.

Each month's total comprises the sum of three months' worth of ratings.

QGEN Financial Forecast

QGEN Earnings Forecast

Next quarter’s earnings estimate for QGEN is CHF0.49 with a range of CHF0.47 to CHF0.51. The previous quarter’s EPS was CHF0.49. QGEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year QGEN has Preformed in-line its overall industry.

QGEN Sales Forecast

Next quarter’s sales forecast for QGEN is CHF435.73M with a range of CHF427.20M to CHF444.92M. The previous quarter’s sales results were CHF431.16M. QGEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year QGEN has Preformed in-line its overall industry.

QGEN Stock Forecast FAQ

What is CH:QGEN’s average 12-month price target, according to analysts?

Based on analyst ratings, Qiagen NV’s 12-month average price target is 41.54.

What is CH:QGEN’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:QGEN, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Qiagen NV a Buy, Sell or Hold?

Qiagen NV has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.

What is Qiagen NV’s share price target?

The average share price target for Qiagen NV is 41.54. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF48.29 ,and the lowest forecast is CHF36.07. The average share price target represents -17.51% Decrease from the current price of CHF50.36.

What do analysts say about Qiagen NV?

Qiagen NV’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Qiagen NV?

To buy shares of CH:QGEN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Qiagen (QGEN) Stock Forecast & Price Target

QGEN Analyst Ratings

QGEN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Qiagen

QGEN Analyst Recommendation Trends

QGEN Financial Forecast

QGEN Earnings Forecast

QGEN Sales Forecast

QGEN Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts